Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on July 9, 2020. The report serves as a disclosure under Regulation FD (Item 7.01) regarding a corporate presentation used by management at investor conferences and meetings. The presentation is attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover for an attached presentation rather than a financial statement itself.
Material Changes
No material changes to financial performance or operations are detailed within the text of this specific filing. The report solely announces the availability of the corporate presentation.
Guidance, Outlook, and Risks
Management commentary, guidance, and risk factors are contained within the attached Exhibit 99.1 (Corporate Presentation dated July 2020). The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for actual financial data, growth metrics, and strategic outlook.
- Verify that the presentation's forward-looking statements are not legally binding as they are not incorporated by reference in this filing.
- Confirm the company's status as an emerging growth company (indicated as not applicable in this filing).
- Check subsequent filings (10-Q or 10-K) for audited or reviewed financial figures corresponding to the period discussed in the presentation.